Literature DB >> 24622347

The clinical features and long-term sequelae of invasive meningococcal disease in children.

Chen Stein-Zamir1, Hanna Shoob, Irina Sokolov, Amin Kunbar, Nitza Abramson, Deena Zimmerman.   

Abstract

We evaluated the outcome of invasive meningococcal disease in children <15 years of age (n = 181). Neisseria meningitidis serogroup B comprised 78% of bacterial isolates. Case fatality rate was 11.6%. In follow-up interviews (115/160 survivors, 72%), at least 1 long-term sequela was reported in 38/115 children (33%), including learning-academic difficulties (22.6%), hearing impairment (7%), neurologic (12.2%), behavioral (14.8%) and motor (10.4%) deficits.

Entities:  

Mesh：

Year:  2014        PMID： 24622347     DOI： 10.1097/INF.0000000000000282

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  21 in total

1.  Cost Effectiveness of Meningococcal Serogroup B Vaccination in College-Aged Young Adults.

Authors:  Ira L Leeds; Vasanthkumar Namasivayam; Assanatou Bamogo; Prithvi Sankhla; Winter M Thayer
Journal:  Am J Prev Med       Date:  2018-12-17       Impact factor: 5.043

2.  Cost-utility analysis of a nationwide vaccination programme against serogroup B meningococcal disease in Israel.

Authors:  Gary M Ginsberg; Colin Block; Chen Stein-Zamir
Journal:  Int J Public Health       Date:  2016-04-22       Impact factor: 3.380

3.  Long-term health and socioeconomic consequences of childhood and adolescent onset of meningococcal meningitis.

Authors:  Line Pickering; Poul Jennum; Rikke Ibsen; Jakob Kjellberg
Journal:  Eur J Pediatr       Date:  2018-06-20       Impact factor: 3.183

4.  Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules.

Authors:  Manish Sadarangani; Tim Sell; Mildred A Iro; Matthew D Snape; Merryn Voysey; Adam Finn; Paul T Heath; Gianni Bona; Susanna Esposito; Javier Diez-Domingo; Roman Prymula; Adefowope Odueyungbo; Daniela Toneatto; Andrew J Pollard
Journal:  CMAJ       Date:  2017-10-16       Impact factor: 8.262

Review 5.  Meningococcal vaccination in pregnancy.

Authors:  Bahaa Abu Raya; Manish Sadarangani
Journal:  Hum Vaccin Immunother       Date:  2018-03-21       Impact factor: 3.452

6.  A cluster of invasive meningococcal disease revealed by the characterization of a novel serogroup B meningococcal clone.

Authors:  L Valinsky; J Jaffe; N Keller; C Block; N Abramson; C Stein-Zamir
Journal:  Epidemiol Infect       Date:  2015-06-26       Impact factor: 4.434

Review 7.  Meningococcal serogroup B vaccine in Italy: state-of-art, organizational aspects and perspectives.

Authors:  C Signorelli; V Chiesa; A Odone
Journal:  J Prev Med Hyg       Date:  2015-08-31

Review 8.  Meningococcal disease in childhood: epidemiology, clinical features and prevention.

Authors:  S Bosis; A Mayer; S Esposito
Journal:  J Prev Med Hyg       Date:  2015-08-31

Review 9.  Systematic Review of Invasive Meningococcal Disease: Sequelae and Quality of Life Impact on Patients and Their Caregivers.

Authors:  Kerstin J Olbrich; Dirk Müller; Sarah Schumacher; Ekkehard Beck; Kinga Meszaros; Florian Koerber
Journal:  Infect Dis Ther       Date:  2018-09-28

10.  The epidemiology of invasive meningococcal disease and the utility of vaccination in Malta.

Authors:  David Pace; Charmaine Gauci; Christopher Barbara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-05-16       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.